Market by Type, Prescription, Therapeutic, Application, End-user, and Country | Forecast 2021-2028
Triton’s report infers that the nasal spray market in Latin America is
expected to witness growth at a compound annual growth rate of 7.46% through
the forecasted phase 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries scrutinized in this market include:
• Brazil
• Mexico
• Rest of Latin America
There is a high occurrence of allergic rhinitis among children in the
Latin American region. Moreover, upper respiratory infections, chronic
obstructive pulmonary disease (COPD), tuberculosis, and lung cancer are leading
causes of mortality across the region. Here, COPD is increasing across major
countries such as Mexico, Brazil, UAE, Argentina, and others. This surge in
respiratory illness predominately drives the progression of the nasal spray
market.
Furthermore, in Brazil, asthma and chronic obstructive pulmonary disease
are major diseases. Along with this, hay fever is highly prevalent among the
adult population across the country. This growth in chronic conditions has
increased the demand for nasal sprays. As a result, these factors are estimated
to widen the scope and growth of the nasal spray market in the country over the
next few years.
On the other hand, the rising air pollution levels are contributing to
the growth of respiratory diseases in Mexico. Additionally, allergic rhinitis
is highly prevalent among children. Besides, the country recorded around 23.5
million new cases of acute respiratory infections in 2019. Furthermore, the
Mexican veterinary pharmaceutical company recently began testing a live influenza
virus-based vaccine for treating COVID-19 as an intranasal spray and injection.
Hence, the aforementioned factors are estimated to support the growth of the
nasal spray market.
Allergan is a pharmaceutical company involved in developing,
manufacturing, and marketing branded pharma products, biologic, device,
surgical, and regenerative medicine products. Additionally, it offers products
for various therapeutics, including eye care, urology, dermatology, and others.
The company sells its brands through retailers, distributors, hospitals,
clinics, and government agencies, among others. Allergan has operations across
multiple regions, including Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA NASAL SPRAY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON NASAL SPRAY MARKET
2.2. KEY
INSIGHTS
2.2.1. ALLERGY
TREATMENTS WITH NASAL SPRAYS
2.2.2. UTILIZING
NASAL SPRAY FOR DIABETES
2.2.3. ENDOMETRIOSIS
TREATMENT WITH NASAL SPRAYS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. EMERGING
INTRANASAL VACCINES FOR COVID-19
2.7.2. INCREASING
ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION
2.7.3. GROWING
USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES
2.8. MARKET
CHALLENGES
2.8.1. COMPLICATIONS
DUE TO EXCESS USE OF NASAL SPRAYS
2.9. MARKET
OPPORTUNITIES
2.9.1. APPLICATION
OF NASAL SPRAYS IN TREATING DEPRESSION
2.9.2. USING
INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
2.9.3. EMPLOYING
NASAL SPRAY AS A VACCINE
3. LATIN
AMERICA NASAL SPRAY MARKET OUTLOOK - BY TYPE
3.1. DECONGESTION
NASAL SPRAY
3.2. STEROID
NASAL SPRAY
3.3. SALTWATER
SOLUTION/SALINE NASAL SPRAY
4. LATIN
AMERICA NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION
4.1. OVER-THE-COUNTER
4.2. PRESCRIBED
5. LATIN
AMERICA NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC
5.1. ANTIHISTAMINE
5.2. NASAL
STEROIDS
5.3. ANTICHOLINERGIC
5.4. MAST
CELL INHIBITOR
6. LATIN
AMERICA NASAL SPRAY MARKET OUTLOOK - BY APPLICATION
6.1. NASAL
CONGESTION
6.2. ALLERGIC
AND NON-ALLERGIC RHINITIS
6.3. VACCINATION
6.4. CNS
DISORDERS
6.5. OTHER
APPLICATIONS
7. LATIN
AMERICA NASAL SPRAY MARKET OUTLOOK - BY END-USER
7.1. HOME
CARE SETTING
7.2. ASC/CLINICS
7.3. PHARMACY
7.4. HOSPITAL
7.5. OTHER END-USERS
8. LATIN
AMERICA NASAL SPRAY MARKET – REGIONAL OUTLOOK
8.1. BRAZIL
8.2. MEXICO
8.3. REST
OF LATIN AMERICA
9. COMPETITIVE
LANDSCAPE
9.1. AKORN
9.2. ALLERGAN
9.3. APOTEX
INC
9.4. BHARAT
BIOTECH
9.5. CATALENT
INC
9.6. CIPLA
LIMITED
9.7. GLAXOSMITHKLINE
9.8. JOHNSON
AND JOHNSON
9.9. NOVARTIS
INTERNATIONAL AG
9.10. PFIZER
INC
9.11. PROCTOR
AND GAMBLE CO
9.12. SANOTIZE
RESEARCH AND DEVELOPMENT
9.13. SUN
PHARMACEUTICALS INDUSTRIES LTD
9.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
9.15. VIATRIS
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA NASAL
SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LATIN AMERICA NASAL
SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 4: LATIN AMERICA NASAL
SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 5: LATIN AMERICA NASAL
SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA NASAL
SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA NASAL
SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA NASAL
SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: LATIN AMERICA NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE
3: LATIN AMERICA NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN
$ MILLION)
FIGURE
4: LATIN AMERICA NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $
MILLION)
FIGURE
5: LATIN AMERICA NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY,
2021-2028 (IN $ MILLION)
FIGURE
6: LATIN AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)
FIGURE
7: LATIN AMERICA NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $
MILLION)
FIGURE
8: LATIN AMERICA NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)
FIGURE
9: LATIN AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)
FIGURE
10: LATIN AMERICA NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $
MILLION)
FIGURE
11: LATIN AMERICA NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $
MILLION)
FIGURE
12: LATIN AMERICA NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $
MILLION)
FIGURE
13: LATIN AMERICA NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $
MILLION)
FIGURE
14: LATIN AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE
15: LATIN AMERICA NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $
MILLION)
FIGURE
16: LATIN AMERICA NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS,
2021-2028 (IN $ MILLION)
FIGURE
17: LATIN AMERICA NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)
FIGURE
18: LATIN AMERICA NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $
MILLION)
FIGURE
19: LATIN AMERICA NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $
MILLION)
FIGURE
20: LATIN AMERICA NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE
21: LATIN AMERICA NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $
MILLION)
FIGURE
22: LATIN AMERICA NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)
FIGURE
23: LATIN AMERICA NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)
FIGURE
24: LATIN AMERICA NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)
FIGURE
25: LATIN AMERICA NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $
MILLION)
FIGURE
26: LATIN AMERICA NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE
27: BRAZIL NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
28: MEXICO NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
29: REST OF LATIN AMERICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)